

| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 414.72 |
| Log P | RDKit | 8.02 |
| Topological polar surface area (Å2) | RDKit | 20.23 |
| Number of hydrogen bond acceptors | RDKit | 1 |
| Number of hydrogen bond donors | RDKit | 1 |
| Number of carbon atoms | RDKit | 29 |
| Number of heavy atoms | RDKit | 30 |
| Number of heteroatoms | RDKit | 1 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 9 |
| Stereochemical complexity | RDKit | 0.31 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 2 |
| Number of sp3 hybridized carbon atoms | RDKit | 27 |
| Shape complexity | RDKit | 0.93 |
| Number of rotatable bonds | RDKit | 6 |
| Number of aliphatic carbocycles | RDKit | 4 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 4 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 4 |
| Number of saturated carbocycles | RDKit | 3 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 3 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 4 |

| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 1 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 2 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.436096 |

| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Poorly soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -2.20 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 1 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |

| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000061 | ENSG00000134538 | SLCO1B1 | 10599 | ChEMBL, NPASS |
| TAR_EXP_001647 | ENSG00000077498 | TYR | 7299 | ChEMBL, NPASS |
| TAR_EXP_001203 | ENSG00000181929 | PRKAG1 | 5571 | ChEMBL |
| TAR_EXP_001197 | ENSG00000131791 | PRKAB2 | 5565 | ChEMBL |
| TAR_EXP_001196 | ENSG00000111725 | PRKAB1 | 5564 | ChEMBL |
| TAR_EXP_001195 | ENSG00000162409 | PRKAA2 | 5563 | ChEMBL |
| TAR_EXP_001194 | ENSG00000132356 | PRKAA1 | 5562 | ChEMBL |
| TAR_EXP_001150 | ENSG00000070501 | POLB | 5423 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000004 | ENSG00000094631 | HDAC6 | 10013 | ChEMBL |
| TAR_EXP_001140 | ENSG00000115592 | PRKAG3 | 53632 | ChEMBL |
| TAR_EXP_001058 | ENSG00000106617 | PRKAG2 | 51422 | ChEMBL |
| TAR_EXP_000747 | ENSG00000138413 | IDH1 | 3417 | ChEMBL, NPASS |
| TAR_EXP_000660 | ENSG00000082701 | GSK3B | 2932 | ChEMBL |
| TAR_EXP_000616 | ENSG00000111700 | SLCO1B3 | 28234 | ChEMBL, NPASS |
| TAR_EXP_000405 | ENSG00000180210 | F2 | 2147 | ChEMBL, NPASS |
| TAR_EXP_000322 | ENSG00000197635 | DPP4 | 1803 | ChEMBL, NPASS |
| TAR_EXP_000280 | ENSG00000160868 | CYP3A4 | 1576 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000276 | ENSG00000272532 | CYP2D6 | 1565 | ChEMBL, NPASS |
| TAR_EXP_001106 | ENSG00000085563 | ABCB1 | 5243 | ChEMBL |